In this issue of Blood, Ding et al demonstrated anti–programmed death 1 (anti–PD-1) responses that may benefit chronic lymphocytic leukemia (CLL) patients with Richter transformation (RT) but did not show activity in non-RT CLL patients.1
CITATION STYLE
Pagel, J. M. (2017, June 29). A Richter transformation PD-1 block party. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-05-781229
Mendeley helps you to discover research relevant for your work.